Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience.
Yasin SezginOgur KarhanSerdar IleriSenar EbincSezai TuncZuhat UrakciPublished in: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP (2024)
Chemotherapy, Mesothelioma, Prognosis, Gemcitabine, Progression-free survival.